U.S. Patent 7711402 was awarded to DexCom, Inc. on 2010-05-04 and describes a “Device and method for determining analyte levels.” This patent has been cited 354 times by other U.S. patents which places it in the top 500 cited patents since 2010 according to our law firm research, and makes it of the most innovative medical technology patents in the field of instruments. The abstract states:

Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time. Link: U.S. Patent 7711402

This patent was originally filed on 2004-12-22 which gives it a processing time of 1959 days, compared to an average processing time of 1696 in the field. DexCom, Inc. has 423 total patents. The first named inventor is Stuart J. Updike of Madison, NC. The primary examiner was Robert L Nasser.

Select Patents monitors top medical technology patents and instruments patents which have been allowed and granted worldwide. If you would like legal advice regarding a patent or would like to file a patent go to https://selectpatents.wpengine.com/contact/